Hot Investor Mandate: Investment Firm Partnered with Family Office Invests in Early-Stage Therapeutics, Devices, Diagnostics Companies Across the USA

4 Feb

A firm dedicated to accelerating the growth of seed-stage life sciences companies operates in partnership with a USA-based family office. The firm invests $250-500K in early financing rounds within high-quality syndicates. The firm invests in companies based in the U.S.

The firm is seeking investments in next-generation therapeutics, medical device, and diagnostics companies. Within the therapeutics sector, the firm invests in cell, gene, oligonucleotide, and microbial therapies, as well as other targeted therapies for well-defined diseases. Typical investments occur at the stage of lead optimization and IND-enabling studies. Within MedTech, the firm invests in platforms leveraging novel biological insights, including cellular and molecular diagnostics, biomaterials, and bio-active implants. Typical investment stage is during late-stage product development approaching regulatory clearance and commercialization.

The firm does not have any specific company or management team requirements. The firm is a strategic as well as financial investor, helping companies develop relationships and accelerate growth.

If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: